Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03542708 · ClinicalTrials.gov registry record · NA
Injections of Autologous PRP in Women With Primary Ovarian Insufficiency
A NA study, sponsored by Center for Human Reproduction.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT03542708 is a NA study that has completed, run by Center for Human Reproduction. The registered enrollment target is 34 participants.
The verdict
NCT03542708, a NA study, has completed, sponsored by Center for Human Reproduction.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
Premature ovarian failure is a loss of normal function before age 40, leading to infertility and hypoestrogenism. This study will involve only adult women with a diagnosis of POI. Participants will receive injections of autologous PRP in one randomly selected ovary.
Interventions
- PROCEDURE A-PRP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2018-07-25 |
| Est. Completion | 2024-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03542708
The ClinicalTrials.gov registry entry for NCT03542708 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for Human Reproduction, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which A-PRP is the first listed.
NCT03542708 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03542708 about?
NCT03542708 is a clinical study titled "Injections of Autologous PRP in Women With Primary Ovarian Insufficiency". Premature ovarian failure is a loss of normal function before age 40, leading to infertility and hypoestrogenism. This study will involve only adult women with a diagnosis of POI. Participants will receive injections of autologous PRP in one randomly selected ovary.
What is the current status of trial NCT03542708?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2018-07-25. Estimated completion is 2024-04-01.
What interventions are being tested in trial NCT03542708?
The interventions under investigation include: A-PRP (PROCEDURE).
Who is sponsoring clinical trial NCT03542708?
This trial is sponsored by Center for Human Reproduction, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.